Hdfc Pharma And Healthcare Fund

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:

1. Returns: It captures the increment in the investment's value during the investment period, articulated as either a percentage or a monetary denomination. We carefully examined four return parameters of this fund to gauge its performance. The return parameters have been divided into three performance groups: the top 25%, parameters below the top 25% but exceeding the average, and parameters below the average mark. Please find the detailed analysis below.
   1. Top 25%: Four return parameters of the HDFC Pharma And Healthcare Fund are in the top 25% in the category, as shown below:
      
      • 1M Return %
      • 3M Return %
      • 6M Return %
      • 1Y Return %
   2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
   3. Below Average: HDFC Pharma And Healthcare Fund has no return parameters that are below average in the category.
2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For HDFC Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
   1. Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
   2. Below Average but Above the Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
   3. Above Average: HDFC Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated zero risk-adjusted performance parameters of the fund.
   1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
   2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
   3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.

_{Not able to see in mobile!!! save the chart by clicking on camera icon.}

Date	Hdfc Pharma And Healthcare Fund NAV Regular Growth	Hdfc Pharma And Healthcare Fund NAV Direct Growth
21-02-2025	15.166	15.426
20-02-2025	15.421	15.685
19-02-2025	15.312	15.574
18-02-2025	15.261	15.521
17-02-2025	15.357	15.618
14-02-2025	15.173	15.43
13-02-2025	15.57	15.834
12-02-2025	15.524	15.786
11-02-2025	15.593	15.856
10-02-2025	16.026	16.296
07-02-2025	16.486	16.762
06-02-2025	16.515	16.79
05-02-2025	16.461	16.736
04-02-2025	16.18	16.449
03-02-2025	15.959	16.224
31-01-2025	15.878	16.14
30-01-2025	15.785	16.045
29-01-2025	15.66	15.917
28-01-2025	15.217	15.467
27-01-2025	15.442	15.695
24-01-2025	15.889	16.147
23-01-2025	16.266	16.531
22-01-2025	16.058	16.318
21-01-2025	16.09	16.35